FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/01/2024
Voltar para busca
Dado oficial do USPTO
BIOSYNEX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BIOSYNEX
ST13
US500000079313560Classe
1, 5, 10, 42
Pedido
79313560
Registro
7159430
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
44
Atualização mais recente
02/01/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 10, 42
Data de depósito
11/05/2021
Data de registro
12/09/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/09/2023
Última transação
12/09/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
FR
Examinador
SEVERSON, JUSTIN
Unidade examinadora
M20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
BIOSYNEX
Representantes
JOSEPH SOFER IPSILON USA, LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical products for use in industry and science; chemical reagentsother than for medical or veterinary purposes ; diagnostic preparations other than for medical or veterinary purposes ; Chemically-treated nonmedical strips for chemical and biological analysis
Classe 5
Chemical and biological reagents and products for medical or veterinary purposesreagents for use in diagnostic testsreagents for use in diagnostic tests for screening purposesreagents for medical usechemical reagents for medical purposesdiagnostic biomarker reagents for medical use; immunoassay reagents for medical usereagent paper for medical purposes; reagents and preparations for pregnancy testschemical preparations for use in DNA medical analysis and Chemicals for use in RNA analysis for medical purposes; diagnostic products for medical purposesmedical diagnostic test strips for the detection of coronavirusvirusesbacteria or parasite for medical purposesmedical diagnostic test strips for measuring blood glucose levelsmedical diagnostic test strips for measuring cholesterol levelstriglyceridescardiac markers or any other biomedical marker; testing kits comprised of medical diagnostic agentspreparations and substances for medical purposes for use in disease detectioncoronavirusHIVrespiratory viral infectionshepatitis Bhepatitis Cinfluenzainfectious mononucleosisdenguenorovirusrotavirusadenovirusurinary tract infectionscolorectal cancerC-reactive proteincyclic citrullinated peptidepremature rupture of the fetal membranesChlamydia trachomatishelicobacter pylorilegionnaire's diseasepneumoniasyphilistetanusmalariamycosesherpesrubellawhooping coughLyme disease; preparations and substances for medical purposes for use in drugs detectionamphetaminesbuprenorphinecocainecotininemethadonefentanylmethamphetaminesmorphineoxycodonephencyclidinecannabistramadol; pregnancy test kits and ovulation test kits for home use; diagnostic test kits comprised of medical diagnosticfor medical purposes for the detection of coronavirusvirusesbacteria or parasite for medical purposes; in vitro diagnostic preparations for medical use for the detection of coronavirusvirusesbacteria or parasite for medical purposes; self-testing diagnostic kits comprising in vitro diagnostic agentspreparations and substances for medical purposes for the detection of coronavirusvirusesbacteria or parasite for medical purposes; medical diagnostic test kits for the detection of coronavirusvirusesbacteria or parasite for medical purposes; medical diagnostic reagents and assays for testing of body fluids for the detection of coronavirusvirusesbacteria or parasite for medical purposes; medical diagnostic reagents; chemical reagents for medical or veterinary purposes
Classe 10
Diagnostic apparatus for medical purposesblood testing apparatus; genetic testing apparatus for medical purposes; diagnostic test readers for medical use; medical diagnostic apparatus for testing DNA and RNA samples; medical apparatus and instrumentsinstruments for loop-mediated isothermal amplification for medical purposes; quantitative Polymerase Chain Reaction PCR instruments for medical use; real-time polymerase chain reaction (PCR) instruments for medical purposes; testing instruments for medical diagnostic purposesfor the detection of coronavirusvirusesbacteria or parasite for medical purposes; capillary tubes for samples; medical specimen cups; specimen cup holders; apparatus for taking body fluid samplesmedical devices for obtaining body fluid samples; gloves for medical purposessanitary masks for medical purposesthermometers for medical usechemically activated hot and cold gel packs for medical purposes; cooling patches for medical purposes; Ice bags for medical purposesfirst-aid cooling patcheselastic bandagesBandages for orthopaedic purposes
Classe 42
Chemical analysis and research services; biological research; bacteriological research; chemical research; pharmaceutical research services; calibration of devices employed in such services
Publicações
Histórico de despachos e eventos da marca no USPTO.
44 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/12/2023
FIMP
FINAL DISPOSITION PROCESSED
12/12/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/12/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/09/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
12/09/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27/06/2023
PUBO
PUBLISHED FOR OPPOSITION
27/06/2023
GPNX
NOTIFICATION PROCESSED BY IB
26/06/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/06/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/06/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/06/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/05/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
24/05/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
24/05/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
24/05/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
24/05/2023
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
28/04/2023
EXPI
EX PARTE APPEAL-INSTITUTED
09/03/2023
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
09/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/03/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/03/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/12/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
23/11/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
23/11/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/09/2022
GNFR
FINAL REFUSAL E-MAILED
09/09/2022
CNFR
FINAL REFUSAL WRITTEN
09/09/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
23/08/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
23/08/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
23/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/08/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/08/2022
RFNT
REFUSAL PROCESSED BY IB
27/02/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/02/2022
RFRR
REFUSAL PROCESSED BY MPU
07/02/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/01/2022
CNRT
NON-FINAL ACTION WRITTEN
19/01/2022
DOCK
ASSIGNED TO EXAMINER
19/01/2022
MAFR
APPLICATION FILING RECEIPT MAILED
29/06/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/06/2021
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
17/06/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIOSYNEX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.